IRadimed Corporation
IRMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $760 | $667 | $698 |
| - Cash | $57 | $53 | $50 | $52 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $707 | $617 | $646 |
| Revenue | $21 | $20 | $20 | $19 |
| % Growth | 3.9% | 4.6% | 0.6% | – |
| Gross Profit | $16 | $16 | $15 | $15 |
| % Margin | 77.8% | 78.2% | 76.1% | 76.1% |
| EBITDA | $8 | $8 | $6 | $7 |
| % Margin | 36.2% | 38.8% | 28.8% | 33.7% |
| Net Income | $6 | $6 | $5 | $5 |
| % Margin | 26.3% | 28.3% | 24% | 26.5% |
| EPS Diluted | 0.434 | 0.45 | 0.37 | 0.4 |
| % Growth | -3.6% | 21.6% | -7.5% | – |
| Operating Cash Flow | $7 | $8 | $4 | $6 |
| Capital Expenditures | -$1 | -$3 | -$4 | -$3 |
| Free Cash Flow | $6 | $5 | $1 | $3 |